Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

The current system can't fully test all combination treatments, so alternative methods and regulatory flexibility are needed.

New cancer drugs often cause skin and nail problems.

Asynchronous telemedicine for acne treatment is effective and improves access and productivity.

The Swedish Hairdex-S is a reliable tool for assessing quality of life in Alopecia Areata patients.

The new measure helps understand the personal and emotional impact of hair loss in alopecia areata patients.

Recipient site scalp necrosis in hair transplantation is linked to microvascular injury and regional vascular vulnerability, especially in the frontal and mid-scalp areas.

Hair loss is common, has a big psychological impact, and rosemary oil is effective for hair regrowth.

Hair loss is common, impacts mental health, and rosemary oil is effective for regrowth.

Africa needs its own dermatology guidelines to address unique skin challenges and improve care.

People with androgenetic alopecia often experience more anxiety, depression, and lower self-esteem.

Men with male pattern baldness may be more at risk for severe COVID-19, and anti-androgen treatments could offer protection.

Different skin conditions show distinct types of vessel inflammation, a new quality of life index for vulval disease is reliable, a certain intrauterine system might be linked to chronic vaginal yeast infections, and oral minoxidil reduces hair loss in women.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Severe alopecia areata greatly impacts quality of life, mental health, and daily activities.

Alopecia areata cases in children are rising, especially in females and low-income regions, with a projected increase in China and decrease in the USA.

Patients with certain skin diseases are willing to spend significant time on treatment, indicating a high impact on their lives and a need for better treatments.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

Finasteride is not proven to cause depression or suicide, and careful patient monitoring is advised.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

Alopecia areata leads to significantly higher healthcare costs due to more doctor visits and prescriptions.

SLE is rare in Uganda but often has complications and overlaps with rheumatoid arthritis.

Alopecia areata affects life quality differently based on its severity.

Patients with fewer past treatments for alopecia areata respond better to baricitinib.

Clinical pharmacists are crucial in improving patient safety by reporting medication errors in hospitals.

Early diagnosis and personalized treatment for PCOS are crucial, especially for young women in West Bengal, India.

A hand-held dermatoscope helped differentiate between pressure-induced alopecia and alopecia areata in a young patient, who then experienced hair regrowth within a month.

A man experienced hair loss after getting COVID-19, which improved with treatment and might have been triggered by stress related to the illness.

Alopecia areata causes significant psychological distress in cancer patients, needing integrated care.